N-TproBNP as biomarker in systemic sclerosis

Tommaso Schioppo, Carolina Artusi, Teresa Ciavarella, Francesca Ingegnoli, Antonella Murgo, Silvana Zeni, Cecilia Chighizola, Pier Luigi Meroni

Research output: Contribution to journalArticle

Abstract

Systemic sclerosis (SSc) is a connective tissue disorder characterized by tissue fibrosis affecting the skin and internal organs, fibroproliferative vasculopathy, and autoimmune activation. SSc still heralds a poor prognosis with significant morbidity and mortality. Early detection of organ involvement is critical as currently available treatments are most effective when started early. Many candidate biomarkers have been investigated in the past two decades. However, despite the enormous efforts, no accurate tool to predict the pattern of organ involvement and to assess disease activity has been yet identified. The N-terminal fragment of probrain natriuretic peptide (N-TproBNP) is a neurohormone released by ventricular myocytes in response to pressure overload. N-TproBNP is highly relevant for diagnosis, prognosis, and prediction of pulmonary arterial hypertension in SSc. Moreover, several studies support its potential benefit for cardiac assessment of scleroderma patients. Conversely, the role of N-TproBNP as surrogate marker of pulmonary fibrosis and skin involvement is much less clear.We provide an extensive review of the studies that have previously investigated the role of N-TproBNP as candidate biomarker in scleroderma manifestations, presenting also the findings of a recent study we conducted in a cohort of 87 SSc patients.

Original languageEnglish
Pages (from-to)292-301
Number of pages10
JournalClinical Reviews in Allergy and Immunology
Volume43
Issue number3
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Natriuretic Peptides
Systemic Scleroderma
Biomarkers
Skin
Pulmonary Fibrosis
Pulmonary Hypertension
Connective Tissue
Muscle Cells
Neurotransmitter Agents
Fibrosis
Morbidity
Pressure
Mortality
Therapeutics

Keywords

  • Biomarker
  • Interstitial lung disease
  • N-TproBNP
  • Pulmonary arterial hypertension
  • Systemic sclerosis

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Schioppo, T., Artusi, C., Ciavarella, T., Ingegnoli, F., Murgo, A., Zeni, S., ... Meroni, P. L. (2012). N-TproBNP as biomarker in systemic sclerosis. Clinical Reviews in Allergy and Immunology, 43(3), 292-301. https://doi.org/10.1007/s12016-012-8312-4

N-TproBNP as biomarker in systemic sclerosis. / Schioppo, Tommaso; Artusi, Carolina; Ciavarella, Teresa; Ingegnoli, Francesca; Murgo, Antonella; Zeni, Silvana; Chighizola, Cecilia; Meroni, Pier Luigi.

In: Clinical Reviews in Allergy and Immunology, Vol. 43, No. 3, 12.2012, p. 292-301.

Research output: Contribution to journalArticle

Schioppo, T, Artusi, C, Ciavarella, T, Ingegnoli, F, Murgo, A, Zeni, S, Chighizola, C & Meroni, PL 2012, 'N-TproBNP as biomarker in systemic sclerosis', Clinical Reviews in Allergy and Immunology, vol. 43, no. 3, pp. 292-301. https://doi.org/10.1007/s12016-012-8312-4
Schioppo T, Artusi C, Ciavarella T, Ingegnoli F, Murgo A, Zeni S et al. N-TproBNP as biomarker in systemic sclerosis. Clinical Reviews in Allergy and Immunology. 2012 Dec;43(3):292-301. https://doi.org/10.1007/s12016-012-8312-4
Schioppo, Tommaso ; Artusi, Carolina ; Ciavarella, Teresa ; Ingegnoli, Francesca ; Murgo, Antonella ; Zeni, Silvana ; Chighizola, Cecilia ; Meroni, Pier Luigi. / N-TproBNP as biomarker in systemic sclerosis. In: Clinical Reviews in Allergy and Immunology. 2012 ; Vol. 43, No. 3. pp. 292-301.
@article{1855c9b7be5c4e928cd640c037b8171b,
title = "N-TproBNP as biomarker in systemic sclerosis",
abstract = "Systemic sclerosis (SSc) is a connective tissue disorder characterized by tissue fibrosis affecting the skin and internal organs, fibroproliferative vasculopathy, and autoimmune activation. SSc still heralds a poor prognosis with significant morbidity and mortality. Early detection of organ involvement is critical as currently available treatments are most effective when started early. Many candidate biomarkers have been investigated in the past two decades. However, despite the enormous efforts, no accurate tool to predict the pattern of organ involvement and to assess disease activity has been yet identified. The N-terminal fragment of probrain natriuretic peptide (N-TproBNP) is a neurohormone released by ventricular myocytes in response to pressure overload. N-TproBNP is highly relevant for diagnosis, prognosis, and prediction of pulmonary arterial hypertension in SSc. Moreover, several studies support its potential benefit for cardiac assessment of scleroderma patients. Conversely, the role of N-TproBNP as surrogate marker of pulmonary fibrosis and skin involvement is much less clear.We provide an extensive review of the studies that have previously investigated the role of N-TproBNP as candidate biomarker in scleroderma manifestations, presenting also the findings of a recent study we conducted in a cohort of 87 SSc patients.",
keywords = "Biomarker, Interstitial lung disease, N-TproBNP, Pulmonary arterial hypertension, Systemic sclerosis",
author = "Tommaso Schioppo and Carolina Artusi and Teresa Ciavarella and Francesca Ingegnoli and Antonella Murgo and Silvana Zeni and Cecilia Chighizola and Meroni, {Pier Luigi}",
year = "2012",
month = "12",
doi = "10.1007/s12016-012-8312-4",
language = "English",
volume = "43",
pages = "292--301",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - N-TproBNP as biomarker in systemic sclerosis

AU - Schioppo, Tommaso

AU - Artusi, Carolina

AU - Ciavarella, Teresa

AU - Ingegnoli, Francesca

AU - Murgo, Antonella

AU - Zeni, Silvana

AU - Chighizola, Cecilia

AU - Meroni, Pier Luigi

PY - 2012/12

Y1 - 2012/12

N2 - Systemic sclerosis (SSc) is a connective tissue disorder characterized by tissue fibrosis affecting the skin and internal organs, fibroproliferative vasculopathy, and autoimmune activation. SSc still heralds a poor prognosis with significant morbidity and mortality. Early detection of organ involvement is critical as currently available treatments are most effective when started early. Many candidate biomarkers have been investigated in the past two decades. However, despite the enormous efforts, no accurate tool to predict the pattern of organ involvement and to assess disease activity has been yet identified. The N-terminal fragment of probrain natriuretic peptide (N-TproBNP) is a neurohormone released by ventricular myocytes in response to pressure overload. N-TproBNP is highly relevant for diagnosis, prognosis, and prediction of pulmonary arterial hypertension in SSc. Moreover, several studies support its potential benefit for cardiac assessment of scleroderma patients. Conversely, the role of N-TproBNP as surrogate marker of pulmonary fibrosis and skin involvement is much less clear.We provide an extensive review of the studies that have previously investigated the role of N-TproBNP as candidate biomarker in scleroderma manifestations, presenting also the findings of a recent study we conducted in a cohort of 87 SSc patients.

AB - Systemic sclerosis (SSc) is a connective tissue disorder characterized by tissue fibrosis affecting the skin and internal organs, fibroproliferative vasculopathy, and autoimmune activation. SSc still heralds a poor prognosis with significant morbidity and mortality. Early detection of organ involvement is critical as currently available treatments are most effective when started early. Many candidate biomarkers have been investigated in the past two decades. However, despite the enormous efforts, no accurate tool to predict the pattern of organ involvement and to assess disease activity has been yet identified. The N-terminal fragment of probrain natriuretic peptide (N-TproBNP) is a neurohormone released by ventricular myocytes in response to pressure overload. N-TproBNP is highly relevant for diagnosis, prognosis, and prediction of pulmonary arterial hypertension in SSc. Moreover, several studies support its potential benefit for cardiac assessment of scleroderma patients. Conversely, the role of N-TproBNP as surrogate marker of pulmonary fibrosis and skin involvement is much less clear.We provide an extensive review of the studies that have previously investigated the role of N-TproBNP as candidate biomarker in scleroderma manifestations, presenting also the findings of a recent study we conducted in a cohort of 87 SSc patients.

KW - Biomarker

KW - Interstitial lung disease

KW - N-TproBNP

KW - Pulmonary arterial hypertension

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84871660172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871660172&partnerID=8YFLogxK

U2 - 10.1007/s12016-012-8312-4

DO - 10.1007/s12016-012-8312-4

M3 - Article

C2 - 22669751

AN - SCOPUS:84871660172

VL - 43

SP - 292

EP - 301

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 3

ER -